Dulac Emmanuel 4
4 · PROTEOSTASIS THERAPEUTICS, INC. · Filed Feb 7, 2019
Insider Transaction Report
Form 4
Dulac Emmanuel
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-02-05+30,600→ 30,600 totalExercise: $3.11Exp: 2029-02-05→ Common Stock (30,600 underlying)
Footnotes (1)
- [F1]These securities shall vest and become exercisable in equal quarterly installments starting on May 5, 2019 until the option is fully vested and exercisable on February 5, 2020, subject to continued service.